Bilcare Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 805987,
    "name": "Bilcare",
    "stock_name": "Bilcare",
    "full_name": "Bilcare Ltd",
    "name_url": "stocks-analysis/bilcare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "66.00",
    "chg": 0.87,
    "chgp": "1.34%",
    "dir": 1,
    "prev_price": "65.13",
    "mcapval": "157.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526853,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 43,
    "indexname": "",
    "isin": "INE986A01012",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "9.93 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/bilcare-805987-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bilcare’s Market Evaluation Revised Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bilcare-downgraded-to-strong-sell-by-marketsmojo-amid-weak-fundamentals-3746359",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Bilcare_mojoScore_3746359.png",
        "date": "2025-12-04 11:08:46",
        "description": "Bilcare, a microcap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and operational metrics. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trajectory, and technical outlook amid a volatile market environment."
      },
      {
        "title": "Bilcare Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bilcare-surges-to-upper-circuit-amid-unprecedented-buying-interest-3731441",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Bilcare_only_buyers_3731441.png",
        "date": "2025-11-26 12:55:39",
        "description": "Bilcare Ltd has witnessed extraordinary buying momentum, registering a near 10% gain in a single session with no sellers in the queue, signalling a potential multi-day upper circuit scenario. This surge stands in stark contrast to the broader market’s modest gains, underscoring a remarkable investor appetite for the healthcare services stock."
      },
      {
        "title": "Why is Bilcare falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bilcare-fallingrising-3722163",
        "imagepath": "",
        "date": "2025-11-22 01:11:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>Despite opening the day with a positive gap of 2.2%, the stock was unable to sustain gains and ultimately declined to an intraday low of ₹78, representing a 4.47% drop from its previous close. This intraday volatility highlights a shift in market sentiment during the trading session. The weighted average price indicates that a greater volume of shares traded closer to the day’s low, signalling selling pressure towards the end of the day. Furthermore, Bilcare’s performance today lagged behind its sector by 2.11%, underscoring relative weakness within its industry group.</p>\n<p><strong>Technical Indicators and Investor Behaviour</strong></p>\n<p>From a technical perspective, the stock remains above its 200-day moving average, a long-t..."
      },
      {
        "title": "Why is Bilcare falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bilcare-fallingrising-3713296",
        "imagepath": "",
        "date": "2025-11-18 23:11:26",
        "description": "As of 18-Nov, Bilcare Ltd's stock price is currently at Rs 83.35, reflecting a decline of Rs 4.8 or 5.45%. The stock has been underperforming, having lost 18.32% over the last six days, and today it has traded within a wide range of Rs 10.35, reaching an intraday high of Rs 92.5 and a low of Rs 82.15. Despite being higher than the 100-day and 200-day moving averages, it is lower than the 5-day, 20-day, and 50-day moving averages. The stock's volatility has been high, with an intraday volatility of 5.92%, and while there has been a significant increase in delivery volume, the overall performance has been negative, indicating a challenging environment for the stock.\n\nIn the broader market context, Bilcare's short-term performance has been notably poor compared to the Sensex, which has gained 0.96% over the past week while Bilcare has dropped 16.82%. This stark contrast highlights the stock's struggles relativ..."
      },
      {
        "title": "Bilcare Faces Financial Struggles Despite Strong Liquidity Position and Long-Term Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bilcares-financial-trend-declines-from-flat-to-negative-amid-significant-performance-drop-3712027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Bilcare_fintrenddot_3712027.png",
        "date": "2025-11-18 14:01:33",
        "description": "Bilcare, a microcap in healthcare services, has faced significant financial challenges for the quarter ending September 2025, with a notable decline in key performance metrics. Despite achieving a high liquidity position, the company reported a substantial loss in profit after tax and low net sales, indicating operational difficulties."
      },
      {
        "title": "How has been the historical performance of Bilcare?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-bilcare-3708992",
        "imagepath": "",
        "date": "2025-11-17 23:14:37",
        "description": "Answer:\nThe historical performance of Bilcare shows significant fluctuations in its financial metrics over the years.\n\nBreakdown:\nBilcare's net sales have seen a decline from 2,997.01 Cr in Mar'19 to 788.04 Cr in Mar'25, with a notable drop in Mar'23 at 981.62 Cr and a slight recovery in Mar'24 at 747.18 Cr. Total operating income followed a similar trend, decreasing from 2,997.01 Cr in Mar'19 to 788.04 Cr in Mar'25. The raw material cost has also decreased from 1,631.68 Cr in Mar'19 to 535.89 Cr in Mar'25, while employee costs have increased slightly from 71.87 Cr in Mar'24 to 81.07 Cr in Mar'25. Operating profit (PBDIT) has fluctuated, peaking at 142.31 Cr in Mar'20 and dropping to 63.09 Cr in Mar'25. The profit before tax has been negative in recent years, with -71.34 Cr in Mar'25 compared to -432.52 Cr in Mar'19. The profit after tax also reflects this trend, showing a loss of -56.16 Cr in Mar'25, down ..."
      },
      {
        "title": "How has been the historical performance of Bilcare?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-bilcare-3703645",
        "imagepath": "",
        "date": "2025-11-15 00:08:15",
        "description": "Answer:\nThe historical performance of Bilcare shows a fluctuating trend in its financial metrics over the years, with significant challenges in profitability.\n\nBreakdown:\nBilcare's net sales have seen a decline from 2,997.01 Cr in Mar'19 to 788.04 Cr in Mar'25, with a notable drop in Mar'23 to 981.62 Cr. The total operating income followed a similar trend, decreasing from 2,997.01 Cr in Mar'19 to 788.04 Cr in Mar'25. Raw material costs have also decreased from 1,631.68 Cr in Mar'19 to 535.89 Cr in Mar'25, while employee costs have increased slightly from 616.93 Cr in Mar'19 to 81.07 Cr in Mar'25. The operating profit (PBDIT) has been inconsistent, peaking at 142.31 Cr in Mar'20 and dropping to 63.09 Cr in Mar'25. Profit before tax has remained negative in recent years, with a loss of -71.34 Cr in Mar'25, reflecting ongoing financial difficulties. The consolidated net profit has also been negative, with -28...."
      },
      {
        "title": "Are Bilcare latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-bilcare-latest-results-good-or-bad-3702219",
        "imagepath": "",
        "date": "2025-11-14 19:30:31",
        "description": "Bilcare has reported its financial results for the quarter ending June 2025, revealing several operational challenges. The net sales for this quarter reached Rs 186.36 crore, which is the lowest figure recorded in the last five quarters and reflects a decline of 5.4% compared to the average net sales of Rs 197.01 crore from the previous four quarters. This suggests a negative trend in near-term sales performance, indicating ongoing difficulties in maintaining sales momentum within the competitive healthcare services sector.\n\nIn terms of profitability, the consolidated net profit showed a significant decline, with a reported change of -135.32% compared to the previous quarter. This contrasts sharply with the previous quarter's performance, which had shown a positive growth rate. Additionally, the operating profit margin, excluding other income, also experienced a change, indicating challenges in operational ..."
      },
      {
        "title": "When is the next results date for Bilcare?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bilcare-3681231",
        "imagepath": "",
        "date": "2025-11-07 23:20:09",
        "description": "The next results date for Bilcare is scheduled for 14 November 2025...."
      }
    ],
    "total": 145,
    "sid": "805987",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/bilcare-805987"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jan-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Intimation For Change In Email Address Of The RTA",
      "datetime": "07-Jan-2026",
      "details": "Bilcare Limited has informed the Exchange about change in Email address of the Registrar and Transfer Agent of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Dec-2025",
      "details": "Intimation for Closure of Trading Window for Unaudited Financial Results for the Quarter and Nine Months ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bilcare Ltd has declared <strong>20%</strong> dividend, ex-date: 20 Sep 12",
          "dt": "2012-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bilcare’s Market Evaluation Revised Amidst Challenging Financial Trends

2025-12-04 11:08:46

Bilcare, a microcap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and operational metrics. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trajectory, and technical outlook amid a volatile market environment.

Bilcare Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit

2025-11-26 12:55:39

Bilcare Ltd has witnessed extraordinary buying momentum, registering a near 10% gain in a single session with no sellers in the queue, signalling a potential multi-day upper circuit scenario. This surge stands in stark contrast to the broader market’s modest gains, underscoring a remarkable investor appetite for the healthcare services stock.

Why is Bilcare falling/rising?

2025-11-22 01:11:36

Short-Term Price Movement and Market Context Despite opening the day with a positive gap of 2.2%, the stock was unable to sustain gains and ultimately declined to an intraday low of ₹78, representing a 4.47% drop from its previous close. This intraday volatility highlights a shift in market sentiment during the trading session. The weighted average price indicates that a greater volume of shares traded closer to the day’s low, signalling selling pressure towards the end of the day. Furthermore, Bilcare’s performance today lagged behind its sector by 2.11%, underscoring relative weakness within its industry group. Technical Indicators and Investor Behaviour From a technical perspective, the stock remains above its 200-day moving average, a long-t...

Why is Bilcare falling/rising?

2025-11-18 23:11:26

As of 18-Nov, Bilcare Ltd's stock price is currently at Rs 83.35, reflecting a decline of Rs 4.8 or 5.45%. The stock has been underperforming, having lost 18.32% over the last six days, and today it has traded within a wide range of Rs 10.35, reaching an intraday high of Rs 92.5 and a low of Rs 82.15. Despite being higher than the 100-day and 200-day moving averages, it is lower than the 5-day, 20-day, and 50-day moving averages. The stock's volatility has been high, with an intraday volatility of 5.92%, and while there has been a significant increase in delivery volume, the overall performance has been negative, indicating a challenging environment for the stock. In the broader market context, Bilcare's short-term performance has been notably poor compared to the Sensex, which has gained 0.96% over the past week while Bilcare has dropped 16.82%. This stark contrast highlights the stock's struggles relativ...

Bilcare Faces Financial Struggles Despite Strong Liquidity Position and Long-Term Resilience

2025-11-18 14:01:33

Bilcare, a microcap in healthcare services, has faced significant financial challenges for the quarter ending September 2025, with a notable decline in key performance metrics. Despite achieving a high liquidity position, the company reported a substantial loss in profit after tax and low net sales, indicating operational difficulties.

How has been the historical performance of Bilcare?

2025-11-17 23:14:37

Answer: The historical performance of Bilcare shows significant fluctuations in its financial metrics over the years. Breakdown: Bilcare's net sales have seen a decline from 2,997.01 Cr in Mar'19 to 788.04 Cr in Mar'25, with a notable drop in Mar'23 at 981.62 Cr and a slight recovery in Mar'24 at 747.18 Cr. Total operating income followed a similar trend, decreasing from 2,997.01 Cr in Mar'19 to 788.04 Cr in Mar'25. The raw material cost has also decreased from 1,631.68 Cr in Mar'19 to 535.89 Cr in Mar'25, while employee costs have increased slightly from 71.87 Cr in Mar'24 to 81.07 Cr in Mar'25. Operating profit (PBDIT) has fluctuated, peaking at 142.31 Cr in Mar'20 and dropping to 63.09 Cr in Mar'25. The profit before tax has been negative in recent years, with -71.34 Cr in Mar'25 compared to -432.52 Cr in Mar'19. The profit after tax also reflects this trend, showing a loss of -56.16 Cr in Mar'25, down ...

How has been the historical performance of Bilcare?

2025-11-15 00:08:15

Answer: The historical performance of Bilcare shows a fluctuating trend in its financial metrics over the years, with significant challenges in profitability. Breakdown: Bilcare's net sales have seen a decline from 2,997.01 Cr in Mar'19 to 788.04 Cr in Mar'25, with a notable drop in Mar'23 to 981.62 Cr. The total operating income followed a similar trend, decreasing from 2,997.01 Cr in Mar'19 to 788.04 Cr in Mar'25. Raw material costs have also decreased from 1,631.68 Cr in Mar'19 to 535.89 Cr in Mar'25, while employee costs have increased slightly from 616.93 Cr in Mar'19 to 81.07 Cr in Mar'25. The operating profit (PBDIT) has been inconsistent, peaking at 142.31 Cr in Mar'20 and dropping to 63.09 Cr in Mar'25. Profit before tax has remained negative in recent years, with a loss of -71.34 Cr in Mar'25, reflecting ongoing financial difficulties. The consolidated net profit has also been negative, with -28....

Are Bilcare latest results good or bad?

2025-11-14 19:30:31

Bilcare has reported its financial results for the quarter ending June 2025, revealing several operational challenges. The net sales for this quarter reached Rs 186.36 crore, which is the lowest figure recorded in the last five quarters and reflects a decline of 5.4% compared to the average net sales of Rs 197.01 crore from the previous four quarters. This suggests a negative trend in near-term sales performance, indicating ongoing difficulties in maintaining sales momentum within the competitive healthcare services sector. In terms of profitability, the consolidated net profit showed a significant decline, with a reported change of -135.32% compared to the previous quarter. This contrasts sharply with the previous quarter's performance, which had shown a positive growth rate. Additionally, the operating profit margin, excluding other income, also experienced a change, indicating challenges in operational ...

When is the next results date for Bilcare?

2025-11-07 23:20:09

The next results date for Bilcare is scheduled for 14 November 2025....

View All News